Lipid-Lowering Therapy in Patients with Average Cholesterol and High Cardiovascular Risk, Insights from the Heart Protection Study

Author: Salam, Amar

Source: Cardiovascular Drugs and Therapy, Volume 18, Number 5, September 2004 , pp. 387-389(3)

Publisher: Springer

Buy & download fulltext article:

Price: $47.00 plus tax (Refund Policy)

Abstract:

Although the benefits of cholesterol-lowering with statins has been established for patients with high cholesterol levels as well as for patients with prior occlusive coronary heart disease, substantial uncertainty has existed about the long-term benefits of these agents in particular types of patient, including patients with moderate or low baseline cholesterol levels pre-treatment, women, the elderly, and those with prior occlusive non-coronary vascular disease. The Heart Protection Study was designed to resolve these uncertainties and to provide substantially more safety information of statins. In this report the study is presented with the significance and practical implications of the results briefly discussed.

Keywords: coronary disease; cholesterol; lipid lowering; statins

Document Type: Research article

DOI: http://dx.doi.org/10.1007/s10557-005-5063-y

Affiliations: 1: Department of Cardiology and Cardiovascular Surgery, 011011011011011011011011Hamad Medical Corporation, 3050, 011011011011011011011011011Doha, 011011011011011011011011011Qatar, Email: amaramin@yahoo.com

Publication date: 2004-09-01